Q1 Earnings Forecast for Inozyme Pharma Issued By Wedbush
Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Equities researchers at Wedbush issued their Q1 2025 EPS estimates for shares of Inozyme Pharma in a research report issued on Monday, March 10th. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.43) per share for the quarter. Wedbush currently has a “Outperform” rating and […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Equities researchers at Wedbush issued their Q1 2025 EPS estimates for shares of Inozyme Pharma in a research report issued on Monday, March 10th. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.43) per share for the quarter. Wedbush currently has a “Outperform” rating and […]
